Examen
Page URL: https://www.bionews.org.uk/page_137139

Fertility treatment doesn't boost womb or breast cancer risk

16 July 2018
Appeared in BioNews 958

Assisted reproduction techniques such as IVF do not increase a woman's risk of developing womb or breast cancer, new research has found.

The large study did not find an overall increased risk of these cancers, but did pinpoint a slight increase in risk of non-invasive breast cancer, and ovarian tumours in women who had fertility treatment. The increase in risk for non-invasive breast cancer, which does not grow into normal tissues or spread throughout the body, was associated with the number of treatment cycles a woman had. The increase in the risk of ovarian tumours appeared to be confined to women with other known risk factors for developing this type of cancer.

In the study, Professor Alastair Sutcliffe at University College London and his team used records of the Human Fertilisation and Embryology Authority of more than 250,000 British women who underwent an assisted fertility treatment between 1991 and 2010, linking this data to information obtained from national cancer records.

The team observed the women over an average of 8.8 years. The average age at the time of treatment was 34.5 years, with women having an average of 1.8 treatment cycles. The cause of infertility among the participants studied involved at least one female factor 44 percent of the time and male factors in 33 percent of cases. In 19 percent of cases the cause of infertility was unexplained.

Assisted reproduction techniques using high levels of hormones have long been thought to potentially increase the risk of cancer in women. A landmark study in 2015 seemed to confirm this by finding that the ovarian cancer risk of women undergoing fertility treatment increases by a third.

The authors of the current paper suggest that underlying patient characteristics, rather than the treatment itself, is likely to explain the previous findings. However, the authors acknowledge the limitations of observational studies, highlighting that continuous monitoring of the population who have fertility treatment is essential.

The research was published in the BMJ

RELATED ARTICLES FROM THE BIONEWS ARCHIVE
1 October 2018 - by Dr Maria Botcharova 
Taking contraceptives that contain a low dose of oestrogen has been linked to a reduced rate of ovarian cancer, in a study of almost two million women...
17 September 2018 - by Isobel Steer 
UK scientists have discovered a protein biomarker of early-stage ovarian cancer, which they hope will be detectable in a urine test...
11 June 2018 - by Grace O'Regan 
Chemotherapy is not necessary to treat the most common type of breast cancer in 69 percent of cases, a new study has shown...
4 June 2018 - by Shaoni Bhattacharya 
A new blood test which can detect ten cancers at an early stage is offering hope as a way to screen for multiple cancers...
21 May 2018 - by Christie Whitehouse 
A new study indicates that an important drug used to treat breast cancer is just as effective when the course of treatment is shortened by half.
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.